Cargando…

PReS-FINAL-2328: Developing and validating the new severity score for FMF

Detalles Bibliográficos
Autores principales:	Demirkaya, E, Acikel, C, Gul, A, Gattorno, M, Ben-Chetrit, E, Ozdogan, H, Hashkes, P, Polat, A, Livneh, A, Ozen, S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4043518/ http://dx.doi.org/10.1186/1546-0096-11-S2-P318

Ejemplares similares

PW01-028 – Developing a new severity score for FMF
por: Demirkaya, E, et al.
Publicado: (2013)

PReS-FINAL-2227: QT and JT dispersion in children with FMF
por: Fidanci, K, et al.
Publicado: (2013)

PReS-FINAL-2220: Cochlear involvement in FMF
por: Keskindemirci, G, et al.
Publicado: (2013)

PReS-FINAL-2213: Validation of inadequate drug response and definition of colchicum resistance in FMF
por: Demirkaya, E, et al.
Publicado: (2013)

PReS-FINAL-2204: Developing of a new scale for assessing the adherence to colchicines treatment in pediatric patients with FMF
por: Yesilkaya, S, et al.
Publicado: (2013)

PReS-FINAL-2221: An earliest diagnosis of FMF
por: Keskindemirci, G, et al.
Publicado: (2013)

PReS-FINAL-2222: FMF presenting with the features of malignancy
por: Keskindemirci, G, et al.
Publicado: (2013)

PReS-FINAL-2219: Evaluation of autonomic function in FMF
por: Aktay Ayaz, N, et al.
Publicado: (2013)

PReS-FINAL-2210: Qualitative aspects of autoinflammatory diseases
por: Konukbay, D, et al.
Publicado: (2013)

PReS-FINAL-2226: Assessment of autonomic functions in children with Familial Mediterranean Fever by using heart rate variability measurements
por: Fidanci, K, et al.
Publicado: (2013)

PReS-FINAL-2223: The relationship between FMF, BD and epilepsy
por: Sargsyan, H
Publicado: (2013)

PReS-FINAL-2218: Treatment of colchicines resistant FMF: experience of a pediatric center in Turkey
por: Kara Eroglu, F, et al.
Publicado: (2013)

P01-039 – Autonomic functions in children with FMF
por: Fidanci, K, et al.
Publicado: (2013)

PReS-FINAL-2205: Vascular risk assesment and MMP-3 gene in FMF
por: Sozeri, B, et al.
Publicado: (2013)

PReS-FINAL-2318: The structural and functional changes of biomembrains of FMF and HSP with children
por: Sargsyan, H, et al.
Publicado: (2013)

PReS-FINAL-2195: The comparison of the efficacy of once and twice daily dosage of colchicine in pediatric patients with Familial Mediterranean Fever
por: Polat, A, et al.
Publicado: (2013)

PReS-FINAL-2329: Validation of the autoinflammatory activity index (AIDAI)
por: Piram, M, et al.
Publicado: (2013)

PReS-FINAL-2337: The eurofever registry: 3 years of enrollment
por: Federici, S, et al.
Publicado: (2013)

PReS-FINAL-2194: Evidence-based clinical classification criteria for periodic fevers
por: Federici, S, et al.
Publicado: (2013)

Validity and reliability of medication adherence scale in FMF
por: Fidanci, BE, et al.
Publicado: (2015)

PW01-027 – Predictors and survival of FMF related amyloidosis
por: Demirkaya, E, et al.
Publicado: (2013)

P01-034 – Cancer in FMF: a population based study Israel
por: Brenner, R, et al.
Publicado: (2013)

P01-038 – QT and JT dispersion in children with FMF
por: Fidanci, K, et al.
Publicado: (2013)

PReS-FINAL-2174: The performance of the new slicc criteria for the classification of sle in children
por: Sag, E, et al.
Publicado: (2013)

The familial Mediterranean fever (FMF) 50 score: does it work in a controlled clinical trial? Re-analysis of the trial of rilonacept for patients with colchicine resistant or intolerant FMF
por: Hashkes, P, et al.
Publicado: (2015)

PReS-FINAL-2207: Results from a multicenter international registry of Familial Mediterranean Fever: validation of the new set of pediatric diagnostic criteria
por: Demirkaya, E, et al.
Publicado: (2013)

PReS-FINAL-2358: T helper cells in henoch-schönlein purpura/iga vasculitis
por: Gülhan, B, et al.
Publicado: (2013)

Featuring the phenotype of the FMF prototype
por: Ben-Zvi, I, et al.
Publicado: (2015)

Validity and reliability of medication adherence scale in FMF (adult version)
por: Fidanci, Berna Eren, et al.
Publicado: (2014)

PW01-026 – Validation of pediatric diagnostic criteria in FMF
por: Demirkaya, E, et al.
Publicado: (2013)

Developing of a new scale for assessing the adherence to colchicine treatment in pediatric patients with FMF
por: Yesilkaya, S, et al.
Publicado: (2015)

PW01-025 – Definition of colchicine resistance in FMF
por: Demirkaya, E, et al.
Publicado: (2013)

PReS-FINAL-2324: PAPA syndrome clinical spectrum and IL-1Β release
por: Omenetti, A, et al.
Publicado: (2013)

FMF: an update
por: Ozen, Seza
Publicado: (2014)

OR7-005 – Canakinumab in childhood colchicine resistant FMF
por: Hashkes, PJ, et al.
Publicado: (2013)

Factors affecting cardiovascular morbidity in young FMF patients. A comparative analysis in colchicine treated FMF patients with and without cardiovascular disease
por: Roitman, AJ, et al.
Publicado: (2015)

PReS-FINAL-2258: Final diagnoses of pediatric patients presenting with musculoskeletal symptoms in a center from the eastern Mediterranean
por: Cavkaytar, O, et al.
Publicado: (2013)

P01-032 – Characterization of genetic-negative FMF
por: Ben-Zvi, I, et al.
Publicado: (2013)

PReS-FINAL-2237: The diagnostic challenge of osteolytic bone lesions in autoinflammatory diseases: a case report
por: Caorsi, R, et al.
Publicado: (2013)

PReS-FINAL-2087: Diagnosis of arthritis: history or laboratory?
por: Yurtsever, O, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_as995kssmvcs7pcq5bq020qelv